Shares of McKesson Co. (NYSE:MCK) have been assigned a consensus recommendation of “Hold” from the twenty ratings firms that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and nine have given a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $177.22.
A number of equities research analysts have commented on MCK shares. Zacks Investment Research upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $164.00 target price on the stock in a research note on Wednesday, February 14th. Jefferies Group upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $205.00 target price on the stock in a research note on Wednesday, January 24th. Needham & Company LLC raised their target price on shares of McKesson from $173.00 to $180.00 and gave the stock a “buy” rating in a research note on Tuesday, January 23rd. Robert W. Baird reaffirmed a “buy” rating and set a $200.00 price objective on shares of McKesson in a report on Wednesday, January 17th. Finally, Deutsche Bank started coverage on shares of McKesson in a report on Monday, December 4th. They set a “buy” rating and a $175.00 price objective for the company.
McKesson (NYSE MCK) traded down $1.78 during midday trading on Friday, reaching $155.91. 287,952 shares of the company’s stock were exchanged, compared to its average volume of 1,688,217. McKesson has a 12 month low of $133.82 and a 12 month high of $178.86. The company has a market cap of $32,560.34, a PE ratio of 6.99, a price-to-earnings-growth ratio of 1.50 and a beta of 1.29. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.61 and a current ratio of 1.07.
McKesson (NYSE:MCK) last released its earnings results on Thursday, February 1st. The company reported $3.41 EPS for the quarter, topping analysts’ consensus estimates of $2.92 by $0.49. McKesson had a net margin of 2.34% and a return on equity of 22.98%. The company had revenue of $53.62 billion for the quarter, compared to analysts’ expectations of $51.98 billion. During the same quarter last year, the business earned $3.04 EPS. The firm’s revenue was up 7.0% compared to the same quarter last year. sell-side analysts predict that McKesson will post 12.71 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 2nd. Investors of record on Thursday, March 1st will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date is Wednesday, February 28th. McKesson’s dividend payout ratio (DPR) is presently 6.03%.
In related news, Chairman John H. Hammergren sold 65,000 shares of the firm’s stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $160.00, for a total value of $10,400,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Erin M. Lampert sold 1,413 shares of the firm’s stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $149.38, for a total transaction of $211,073.94. The disclosure for this sale can be found here. Company insiders own 1.20% of the company’s stock.
Several hedge funds have recently bought and sold shares of MCK. Icon Wealth Partners LLC purchased a new position in shares of McKesson in the fourth quarter valued at $111,000. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC grew its holdings in shares of McKesson by 176.6% in the fourth quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 769 shares of the company’s stock valued at $130,000 after purchasing an additional 491 shares in the last quarter. Hikari Tsushin Inc. purchased a new position in shares of McKesson in the fourth quarter valued at $151,000. Wealthcare Advisory Partners LLC purchased a new position in shares of McKesson in the third quarter valued at $155,000. Finally, Virtue Capital Management LLC purchased a new position in McKesson during the fourth quarter worth $180,000. 88.91% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: This story was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at https://ledgergazette.com/2018/03/14/brokerages-set-mckesson-co-mck-target-price-at-177-22.html.
McKesson Company Profile
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.